Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03260023
Title Phase Ib/II of TG4001 and Avelumab in HPV16 Positive R/M Cancers
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Transgene
Indications

vaginal cancer

cervical cancer

penile cancer

anus cancer

vulva cancer

Therapies

Avelumab

Avelumab + Tipapkinogene sovacivec

Age Groups: adult | senior
Covered Countries USA | FRA | ESP


No variant requirements are available.